AstraZeneca Archives | Be Korea-savvy
Samsung Biologics to Manufacture AstraZeneca’s COVID-19 Antibody Combination

Samsung Biologics to Manufacture AstraZeneca’s COVID-19 Antibody Combination

SEOUL, Dec. 14 (Korea Bizwire) — British-Swedish pharmaceutical giant AstraZeneca said Tuesday that Samsung Biologics Co., the biotech arm of Samsung Group, will manufacture its antibody combination against COVID-19. Under an agreement valued at approximately US$380 million, Samsung Biologics will manufacture AZD7442 — AstraZeneca’s combination of two long-acting antibodies in development for the potential treatment [...]

Experts Divided over Decision to Offer AstraZeneca Vaccine Those in 30s and 40s

Experts Divided over Decision to Offer AstraZeneca Vaccine Those in 30s and 40s

SEOUL, Aug. 19 (Korea Bizwire) — Medical experts are divided over the government’s decision to alleviate age requirements for the AstraZeneca’s COVID-19 vaccine, which was originally available only to those over 50 years of age. The Korea Disease Control and Prevention Agency introduced new measures last week that allow citizens over 30 years of age [...]

S. Korea Allows Administration of Leftover AstraZeneca Vaccine Doses to Younger Population

S. Korea Allows Administration of Leftover AstraZeneca Vaccine Doses to Younger Population

SEOUL, Aug. 13 (Korea Bizwire) – South Korea on Friday allowed administration of leftover AstraZenenca COVID-19 vaccine doses to people aged 30 and over amid concerns over unused vaccines being wasted, health authorities said. The country had so far only allowed vaccines manufactured by British-Swedish pharmaceutical giant AstraZeneca and Oxford University to people aged 50 [...]

DARE-19 Phase III Collaboration Between AstraZeneca, Saint Luke’s Mid America Heart Institute and George Clinical Shows Treatment’s Well-Established Safety Profile was Consistent in Patients with COVID-19

DARE-19 Phase III Collaboration Between AstraZeneca, Saint Luke’s Mid America Heart Institute and George Clinical Shows Treatment’s Well-Established Safety Profile was Consistent in Patients with COVID-19

OVERLAND PARK, KS, July 29 (Korea Bizwire) — The findings of DARE-19, a double-blind, placebo-controlled Phase III trial examining Dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19, have been published in The Lancet Diabetes & Endocrinology.  The study was a collaboration of  George Clinical, a global scientifically-backed clinical research organization and Saint Luke’s Mid [...]

S. Korea to Start Vaccinations of Care Workers, Airline Crews

S. Korea to Start Vaccinations of Care Workers, Airline Crews

SEOUL, April 18 (Korea Bizwire) — South Korea will start giving AstraZeneca’s COVID-19 vaccine to health care workers and airline crews this week to speed up the vaccination drive against the pandemic, the health authority said Sunday. Health authorities will administer AstraZeneca vaccines to health care workers for the disabled, seniors and veterans as well [...]

AstraZeneca Vaccine Rollout Resumed, Those Under 30 Excluded

AstraZeneca Vaccine Rollout Resumed, Those Under 30 Excluded

SEOUL, April 11 (Korea Bizwire) – South Korea on Sunday decided to resume administering AstraZeneca vaccines to eligible recipients after temporarily putting the program on hold amid growing concerns over its safety. The use of AstraZeneca’s vaccine will resume Monday, except for those aged 30 and below, according to the Korea Disease Control and Prevention [...]

S. Korea Suspends AstraZeneca Vaccination Programs Due to Concerns over Blood Clots

S. Korea Suspends AstraZeneca Vaccination Programs Due to Concerns over Blood Clots

SEOUL, April 7 (Korea Bizwire) — South Korea decided Wednesday to suspend a AstraZeneca COVID-19 vaccination program for people younger than 60 due to concerns related to blood clots. Set to start on Thursday, AstraZeneca vaccination programs for special education instructors and teachers at kindergarten, elementary, middle and high schools, about 70,000 in total, will [...]

S. Korea Accelerates AstraZeneca Vaccine Rollout as EU Regulator Eases Safety Concerns

S. Korea Accelerates AstraZeneca Vaccine Rollout as EU Regulator Eases Safety Concerns

SEOUL, March 19 (Korea Bizwire) — South Korea is posed to speed up the rollout of the AstraZeneca COVID-19 vaccine as part of its inoculation campaign as the European Union’s medicines regulator assessed that there is no link to blood clots found in some recipients. The European Medicines Agency (EMA) announced Thursday (local time) that [...]